BIM:EPA
BioMerieux SA
€92.20
arrow_upward
+0.60%(+0.55) 1D
Nov 11, 5:35:11 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIM...
Open
€90.85
High
€92.30
Low
€90.50
Mkt. cap
10.65B
Avg. vol.
187.64K
Volume
114.09K
P/E ratio
23.63
52-wk high
€116.10
52-wk low
€65.60
EPS
€3.90
Shares outstanding
118.36M
No. of employees
15K
Open
€90.85
High
€92.30
Low
€90.50
Mkt. cap
10.65B
Avg. vol.
187.64K
Volume
114.09K
P/E ratio
23.63
52-wk high
€116.10
52-wk low
€65.60
EPS
€3.90
Shares outstanding
118.36M
No. of employees
15K
News stories
From web sources and news partners
Yahoo Finance
·
4 hours ago
History Says 1 Month Has Been the S&P 500's Most Reliable Since 1950. It's Only Weeks Away.
Anadolu Ajansı
·
3 hours ago
US stock markets close midweek higher
Eurasia Business News
·
5 hours ago
Stock Market Today: Dow Jones, Nasdaq, S&P 500 Rally on November 11, 2026; Oil Rises, Gold Slips
KuCoin
·
10 hours ago
In June, Bitcoin outperformed the S&P 500 on just 1 in 5 tra
Profile
bioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors.
bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases, cancer screening, and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock exchange. Wikipedia
About BioMerieux SA
CEOPierre Boulud
Employees14.9K
Founded1963
HeadquartersMarcy-l'Étoile, Rhone-Alpes, France
SectorHealth Care
IndustryMedical device
Websitebiomerieux.com